143 related articles for article (PubMed ID: 9373769)
1. Thymostimulin increases natural cytotoxic activity in patients with breast cancer.
Meneses G; Delgado MA; Perez-Machado MA; Prieto A; Alonso R; Carrion F; Lanzos E; Alvarez-Mon M
Int J Immunopharmacol; 1997 Apr; 19(4):187-93. PubMed ID: 9373769
[TBL] [Abstract][Full Text] [Related]
2. Thymostimulin enhances the natural cytotoxic activity of patients with transitional cell carcinoma of the bladder.
Moltó LM; Carballido JA; Manzano L; Olivier C; Lapuerta M; Alvarez-Mon M
Int J Immunopharmacol; 1993 Apr; 15(3):335-41. PubMed ID: 8505146
[TBL] [Abstract][Full Text] [Related]
3. Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.
Liberati AM; Cinieri S; Fizzotti M; Schippa M; Ascani S; De Angelis V; Senatore M; Palmisano L
Med Oncol Tumor Pharmacother; 1989; 6(1):45-52. PubMed ID: 2725094
[TBL] [Abstract][Full Text] [Related]
4. Interferon beta enhances the natural killer activity of patients with bladder carcinoma.
Moltó L; Carballido J; Manzano L; Olivier C; Lapeña P; Alvarez-Mon M
Cancer Immunol Immunother; 1994 Jun; 38(6):406-10. PubMed ID: 8205562
[TBL] [Abstract][Full Text] [Related]
5. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
Hajto T; Hostanska K; Weber K; Zinke H; Fischer J; Mengs U; Lentzen H; Saller R
Nat Immun; 1998; 16(1):34-46. PubMed ID: 9789123
[TBL] [Abstract][Full Text] [Related]
6. IL-12-mediated activation of MHC-unrestricted cytotoxicity of human PBMC subpopulations: synergic action of a plant rhamnogalacturonan.
Klein-Franke A; Anderer FA
Anticancer Res; 1995; 15(6B):2511-6. PubMed ID: 8669815
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
8. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
9. Natural killer activity in patients with breast cancer.
Bonilla F; Alvarez-Mon M; Merino F; Girón JA; Menéndez JL; Espana P; Durántez A
Eur J Gynaecol Oncol; 1990; 11(2):103-9. PubMed ID: 2379508
[TBL] [Abstract][Full Text] [Related]
10. Retinoids, breast cancer and NK cells.
Villa ML; Ferrario E; Trabattoni D; Formelli F; De Palo G; Magni A; Veronesi U; Clerici E
Br J Cancer; 1993 Nov; 68(5):845-50. PubMed ID: 8217599
[TBL] [Abstract][Full Text] [Related]
11. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of interleukin-2 and gamma-interferon production in vitro on cord blood lymphocytes and in vivo on primary cellular immunodeficiency patients with thymic extract (thymostimulin).
Lin CY; Kuo YC; Lin CC; Ou BR
J Clin Immunol; 1988 Mar; 8(2):103-7. PubMed ID: 3131384
[TBL] [Abstract][Full Text] [Related]
13. Human NK-92 Cells Function as Target Cells for Human NK Cells - Implications for CAR NK-92 Therapies.
Bergman H; Sissala N; HÄgerstrand H; Lindqvist C
Anticancer Res; 2020 Oct; 40(10):5355-5359. PubMed ID: 32988854
[TBL] [Abstract][Full Text] [Related]
14. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus].
Zhao XZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Nov; 12(11):669-71, 645. PubMed ID: 1301849
[TBL] [Abstract][Full Text] [Related]
16. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
17. Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease.
Marazuela M; Vargas JA; Alvarez-Mon M; Albarrán F; Lucas T; Durántez A
Eur J Endocrinol; 1995 Feb; 132(2):175-80. PubMed ID: 7858736
[TBL] [Abstract][Full Text] [Related]
18. Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients.
Giacomelli R; Passacantando A; Frieri G; Parzanese I; D'Alò S; Vernia P; Pimpo MT; Petrucci C; Caprilli R; Cifone MG; Tonietti G
Clin Exp Immunol; 1999 Jan; 115(1):72-7. PubMed ID: 9933422
[TBL] [Abstract][Full Text] [Related]
19. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
[TBL] [Abstract][Full Text] [Related]
20. The effects of 2.35-T MR imaging on natural killer cell cytotoxicity with and without interleukin-2.
Prasad N; Lotzová E; Thornby JI; Taber KH
Radiology; 1990 Apr; 175(1):261-3. PubMed ID: 2315491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
